Stock Track | Dr Reddy's Laboratories Plummets 5.41% on Earnings Miss and Trump Tariff Concerns

Stock Track

07/22

Dr Reddy's Laboratories (NYSE:RDY) saw its shares plummet 5.41% during intraday trading on Wednesday, as the stock was hit by disappointing quarterly results and broader sector concerns over proposed U.S. tariffs on generic medicines.

The pharmaceutical company reported first-quarter earnings that significantly missed analyst estimates, with EPS of $0.06 falling 64.71% below the $0.17 consensus. Quarterly sales of $853 million also missed expectations by 7.84% and represented a 14.44% decrease from the same period last year.

Compounding the company-specific issues, shares in generic-drug makers across Asia and Europe declined after former President Donald Trump announced plans to impose a 100% tariff on such drugs starting in August 2028. Analysts noted the plan would hit predominantly China and India, where most generic drugs are manufactured, putting pressure on companies like Dr Reddy's that operate on thinner margins.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1176509502"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176509502\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176509502?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-22 21:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176509502","market":"us","top_or_hot":-1,"title":"Stock Track | Dr Reddy's Laboratories Plummets 5.41% on Earnings Miss and Trump Tariff Concerns","media":"Stock Track","content":"<p>Dr Reddy's Laboratories (NYSE:RDY) saw its shares plummet 5.41% during intraday trading on Wednesday, as the stock was hit by disappointing quarterly results and broader sector concerns over proposed U.S. tariffs on generic medicines.</p><p>The pharmaceutical company reported first-quarter earnings that significantly missed analyst estimates, with EPS of $0.06 falling 64.71% below the $0.17 consensus. Quarterly sales of $853 million also missed expectations by 7.84% and represented a 14.44% decrease from the same period last year.</p><p>Compounding the company-specific issues, shares in generic-drug makers across Asia and Europe declined after former President Donald Trump announced plans to impose a 100% tariff on such drugs starting in August 2028. Analysts noted the plan would hit predominantly China and India, where most generic drugs are manufactured, putting pressure on companies like Dr Reddy's that operate on thinner margins.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Dr Reddy's Laboratories Plummets 5.41% on Earnings Miss and Trump Tariff Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Dr Reddy's Laboratories Plummets 5.41% on Earnings Miss and Trump Tariff Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-22 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dr Reddy's Laboratories (NYSE:RDY) saw its shares plummet 5.41% during intraday trading on Wednesday, as the stock was hit by disappointing quarterly results and broader sector concerns over proposed U.S. tariffs on generic medicines.</p><p>The pharmaceutical company reported first-quarter earnings that significantly missed analyst estimates, with EPS of $0.06 falling 64.71% below the $0.17 consensus. Quarterly sales of $853 million also missed expectations by 7.84% and represented a 14.44% decrease from the same period last year.</p><p>Compounding the company-specific issues, shares in generic-drug makers across Asia and Europe declined after former President Donald Trump announced plans to impose a 100% tariff on such drugs starting in August 2028. Analysts noted the plan would hit predominantly China and India, where most generic drugs are manufactured, putting pressure on companies like Dr Reddy's that operate on thinner margins.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RDY","symbol_name":"如瑞迪博士","start_time":0,"source_url":"","article_id":"1176509502","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176509502","pubTimestamp":1784727158,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Dr Reddy's Laboratories (NYSE:RDY) saw its shares plummet 5.41% during intraday trading on Wednesday, as the stock was hit by disappointing quarterly results and broader sector concerns over proposed...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RDY":"如瑞迪博士"},"translate_title":"股票跟踪 | Dr Reddy's Laboratories 因盈利低迷和特朗普关税担忧暴跌 5.41%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RDY":1},"content_text":"Dr Reddy's Laboratories (NYSE:RDY) saw its shares plummet 5.41% during intraday trading on Wednesday, as the stock was hit by disappointing quarterly results and broader sector concerns over proposed U.S. tariffs on generic medicines.The pharmaceutical company reported first-quarter earnings that significantly missed analyst estimates, with EPS of $0.06 falling 64.71% below the $0.17 consensus. Quarterly sales of $853 million also missed expectations by 7.84% and represented a 14.44% decrease from the same period last year.Compounding the company-specific issues, shares in generic-drug makers across Asia and Europe declined after former President Donald Trump announced plans to impose a 100% tariff on such drugs starting in August 2028. Analysts noted the plan would hit predominantly China and India, where most generic drugs are manufactured, putting pressure on companies like Dr Reddy's that operate on thinner margins.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}